Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Biotechnology Research
Sydney-based EosGene Therapeutics operates in Biotechnology Research. It is privately held, and its site is eosgene.com. It holds one address on record, all in Australia. Headcount on record is 1. Its work is tagged clinical trials. One Australian registration (ABN) is a confirmed match. It is listed alongside six similar brands, mostly in Biotechnology Research.
ABN59660440826
| EOSGENE THERAPEUTICS PTY LTD | ABN 59660440826 |
|---|---|
| Confirmed matches | 0 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
EosGene Therapeutics: Pioneering Gene Therapy for a Brighter Future
EosGene Tx is dedicated to address a significant healthcare challenge of diabetic retinopathy by harnessing the power of CRISPR-based gene therapy. With our ground-breaking liposome delivery technology, we're at the forefront of transforming treatment possibilities.
Our approach employs the revolutionary CRISPR editing tool to precisely target the disease-associated gene, paving the way for therapeutic breakthroughs. To ensure both effectiveness and safety of the therapy, we've developed an innovative liposome delivery technology that achieves the spatial-temporal release of CRISPR agents to the affected retinal cells.
Our objective is clear: to halt or even reverse the progression of diabetic retinopathy by correcting genetic mutations and dysfunctions at their source.
Guided by world-class scientists and business leaders, our team brings a wealth of experience and expertise in the dynamic realm of biotechnology.
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
1 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Names are withheld until a consented source exists.
One New South Wales entity on the ABR: EOSGENE THERAPEUTICS PTY LTD (ABN 59 660 440 826), high confidence.
1 counted staff profiles at January 2026. The brand's self-reported band sits above that count and is not published as a headcount.
One address on record, Australia only. Primary: Sydney.
None linked to this brand.
Seven tags on the brand's own list, among them clinical trials.
4 profiles list EosGene Therapeutics as a peer — 56th percentile in Biotechnology Research. It lists ten peers of its own. SMART CRC and Preview Health list it back.